Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Arabinofuranosyltransferases are a class of enzymes (transferases) that catalyze the transfer of arabinose residues in the polymerization of arabinan and arabinogalactan—key components of the mycobacterial cell wall. These enzymes are essential for building the complex cell wall structure in mycobacteria, such as *Mycobacterium tuberculosis*. Specific enzymes include EmbA, EmbB, EmbC, and AftA, which are crucial for synthesizing arabinogalactan (AG) and lipoarabinomannan (LAM). They are validated drug targets; ethambutol inhibits these enzymes, blocking cell wall biosynthesis.
Inhibition of arabinosyl transferases (EmbA, EmbB, EmbC), blocking cell wall biosynthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arabinofuranosyltransferase.